QDEL
Quidel CorporationNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$1.04B
P/E Ratio
—
EPS
$-16.69
Beta
0.92
52W High
$38.99
52W Low
$14.45
50-Day MA
$21.61
200-Day MA
$26.23
Dividend Yield
—
Profit Margin
-41.50%
Forward P/E
7.23
PEG Ratio
2.06
About Quidel Corporation
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for infectious disease, cardiology, thyroid, general and women's health, eye health, gastrointestinal disease, and toxicology applications globally. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $2.73B |
| Gross Profit (TTM) | $1.28B |
| EBITDA | $562.00M |
| Operating Margin | 4.01% |
| Return on Equity | -46.20% |
| Return on Assets | 1.27% |
| Revenue/Share (TTM) | $40.27 |
| Book Value | $28.28 |
| Price-to-Book | 0.56 |
| Price-to-Sales (TTM) | 0.38 |
| EV/Revenue | 1.372 |
| EV/EBITDA | 21.32 |
| Quarterly Earnings Growth (YoY) | -77.10% |
| Quarterly Revenue Growth (YoY) | 2.20% |
| Shares Outstanding | $68.08M |
| Float | $63.59M |
| % Insiders | 1.01% |
| % Institutions | 124.15% |
Analyst Ratings
Consensus ($34.67 target)
1
Strong Buy2
Buy3
Hold1
Strong SellData last updated: 4/9/2026